Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices 4151 

measurable goals for Federal Programs 

that can be reported as part of the 

budgetary process, thus linking funding 

decisions with performance. 

Performance measures for MCHB 

discretionary grants were initially 

approved in January 2003. Approval 

from OMB is being sought to continue 

the use of these measures. The number 

of measures has been reduced with the 

transfer of a program to the 

Administration for Children and 

Families. The remaining performance 

measures are unchanged from those 

approved in 2003. Some of these 

measures are specific to certain types of 

programs, and will not apply to all 

grantees. Furthermore, these measures 

are based primarily on existing data, 

thereby minimizing the response burden 

consistent with program administration 

and management needs. 

The estimated response burden is as 

follows: 

Form Number of 

respondents 

Responses per 

respondent 

Total 

responses 

Burden per 

response 

Total burden 

hours 

Grant Report .................................................... 631 1 631 6 3,786 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent within 30 days of this notice to: 

John Kraemer, Human Resources and 

Housing Branch, Office of Management 

and Budget, New Executive Office 

Building, Room 10235, Washington, DC 

20503. 

Dated: January 19, 2006. 

Tina M. Cheatham, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. E6–893 Filed 1–24–06; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Health Resources 

and Services Administration (HRSA) 

publishes abstracts of information 

collection requests under review by the 

Office of Management and Budget 

(OMB), in compliance with the 

Paperwork Reduction Act of 1995 (44 

U.S.C. Chapter 35). To request a copy of 

the clearance requests submitted to 

OMB for review, call the HRSA Reports 

Clearance Office on (301) 443–1129. 

The following request has been 

submitted to the Office of Management 

and Budget for review under the 

Paperwork Reduction Act of 1995: 

Proposed Project: The Health 

Professions Student Loan (HPSL) and 

Nursing Student Loan (NSL) Programs: 

Forms (OMB No. 0915–0044): Extension 

The HPSL Program Provides longterm, low-interest loans to students 

attending schools of medicine, 

osteopathic medicine, dentistry, 

veterinary medicine, optometry, 

podiatric medicine, and pharmacy. The 

NSL Program provides long-term, lowinterest loans to students who attend 

eligible schools of nursing in programs 

leading to a diploma in nursing, and an 

associate degree, a baccalaureate degree, 

or a graduate degree in nursing. 

Participating HPSL and NSL schools are 

responsible for determining eligibility of 

applicants, making loans, and collecting 

monies owed by borrowers on their 

outstanding loans. The deferment form 

(HRSA form 519) provides the schools 

with documentation of a borrower’s 

eligibility for deferment. The Annual 

Operating Report (AORHRSA form 501) 

provides the Federal Government with 

information from participating and nonparticipating schools (schools that are 

no longer granting loans but are 

required to report and maintain program 

records, student records, and repayment 

records until all student loans are repaid 

in full and all monies due the Federal 

Government are returned) relating to 

HPSL and NSL program operations and 

financial activities. 

The estimate of burden is as follows: 

Form Number of 

respondents 

Responses 

per 

respondent 

Total 

responses 

Hours per 

responses 

Total burden 

hours 

Deferment HRSA–519 ......................................................... 3,000 1 3,000 1 10 500 

AOR–HRSA–501 ................................................................. 977 1 977 2 4 3,908 

Total Burden ................................................................. 3,977 3,977 4,408 

1 Minutes. 

2 Hours. 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent within 30 days of this notice to: 

John Kraemer, Human Resources and 

Housing Branch, Office of Management 

and Budget, New Executive Office 

Building, Room 10235, Washington, DC 

20503. 

Dated: January 19, 2006. 

Tina M. Cheatham, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. E6–894 Filed 1–24–06; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request 

A Survey of Estimated Glomerular 

Filtration Rate (GFR) Reporting 

Practices of Clinical Laboratories. 

Summary: In compliance with the 

requirement of section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 


wwhite on PROD1PC61 with NOTICES
4152 Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices 

for the opportunity for public comment 

on proposed data collection projects, the 

National Institute of Diabetes and 

Digestive and Kidney Diseases (NIDDK) 

of the National Institutes of Health 

(NIH) will publish periodic summaries 

of proposed projects to be submitted to 

the Office of Management and Budget 

(OMB) for review and approval. 

Proposed Collection: Title: A Survey 

of Estimated GFR Reporting Practices of 

Clinical Laboratories: Type of 

Information Collection Request: New. 

Need and Use of Information Collection: 

This study will assess the level of U.S. 

clinical laboratory reporting of 

estimated GFR as a measure of kidney 

function. This will be accomplished 

through baseline and follow-up surveys 

of a representative sample of clinical 

laboratories in the U.S. Information will 

be used to establish baseline data 

necessary to measure an anticipated 

increased in use of estimated GFR, 

following the implementation of the 

NKDEP’s communications and Lab 

Working Group (LWG) activities 

promoting use of estimated GFR for 

patients at risk for kidney disease. The 

LWG, whose members are experts in 

their field, strongly believes that routine 

reporting of estimated GFR will result in 

a significant increase in early detection 

of chronic kidney disease, therefore 

enabling treatment that can slow or 

prevent patients’ progression to kidney 

failure. Frequency of Response: Baseline 

survey only. Affected Public: Clinical 

laboratory community. Type of 

Respondents: Laboratory directors. The 

annual reporting burden is as follow: 

Estimated Number of Respondents: 

Anticipate 4,126 completed surveys; 

Estimated Number of Responses per 

Respondent: Respondents will complete 

one paper-and-pencil or online survey; 

Average Burden Hours Per Response: 

.083 hours [5 minutes]; and Estimated 

Total Annual Burden Hours Requested: 

342.46 hours. The annualized total cost 

to respondents is estimated at 

$11,759.10. (Note: Completing this 

survey is similar to other data reporting 

carried out by lab directors. Since lab 

directors will be able to responded to 

the survey within their usual workday, 

this collection of information will not 

cost labs.employers additional time and 

money.) There are no Capital Costs to 

report. There are no Operating or 

Maintenance Costs to report. 

Type of respondents 

Estimated 

number of respondents 

Estimated 

number of responses per 

respondent 

Average burden hours per 

response 

Annual total 

burden hours 

requested 

Clinical Laboratory Directors ............................................................................ 4,126 1.0 .083 342.46 

Total .......................................................................................................... 4,126 1.0 .083 342.46 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to responded, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

For Further Information Contact: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Elisa Gladstone, 

MPH, Project Officer, Associate 

Director, National Kidney Disease 

Education Program, National Institute of 

Diabetes and Digestive and Kidney 

Diseases, National Institutes of Health, 

Building 31, Center Dr., Room 9A06, 

Bethesda, MD 20892, or call non-toll 

free number (301) 435–8116 or e-mail 

your request, including your address to, 

gladstonee@niddk.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: January 17, 2006. 

Elisa H. Gladstone, 

MPH, Project Officer, Associate Director, 

National Kidney Disease Education Program, 

National Institute of Diabetes and Digestive 

and Kidney Diseases, National Institutes of 

Health. 

[FR Doc. 06–704 Filed 1–24–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Intraperitoneal Injection of 

Pseudovirions Carrying a Toxin Leads 

to Significantly Reduced Tumor Size 

Michael M. Gottesman et al. (NCI) 

U.S. Provisional Application filed 01 

Dec 2005 (HHS Reference No. E–163–

2005/0–US–01) 

Licensing Contact: Michelle A. Booden; 

301/451–7337; 

boodenm@mail.nih.gov 

SV40-based pseudovirions show great 

promise in the cancer gene therapy 

field. SV40 vectors very efficiently 

deliver genes such as anti-viral agents, 

DNA vaccine, genes for 

chemoprotection, suicide genes, and 

antiangiogenic genes. The immediate 

application for this technology is to 

target plasmid DNA to cancerous cells 

as a gene therapy treatment for various 

human carcinomas. In previous studies, 

NCI investigators Chava Kimchi-Sarfaty 

and Michael Gottesman have 


wwhite on PROD1PC61 with NOTICES